research use only
Cat.No.E1051
| Related Targets | Bcl-2 Caspase PD-1/PD-L1 Ferroptosis p53 Apoptosis related Synthetic Lethality STAT TNF-alpha Ras |
|---|---|
| Other KRas Inhibitors | RMC-7977 Daraxonrasib (RMC-6236) Zoldonrasib (RMC-9805) BI-2852 Adagrasib (MRTX849) HRS-4642 ARS-1620 BI-3406 ARS-853 BAY-293 |
| Molecular Weight | 600.63 | Formula | C33H31F3N6O2 |
Storage (From the date of receipt) | 3 years -20°C powder |
|---|---|---|---|---|---|
| CAS No. | 2621928-55-8 | -- | Storage of Stock Solutions |
|
|
|
In vitro |
DMSO
: 100 mg/mL
(166.49 mM)
Ethanol : 100 mg/mL Water : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Targets/IC50/Ki |
KRAS G12D
|
|---|---|
| In vitro |
MRTX1133 not only possesses single-digit nM potency in a cellular proliferation assay, but also demonstrates tumour regressions in the Panc 04.03 xenograft model. |
| In vivo |
MRTX1133 is a highly selective inhibitor of mutant KRAS G12D and can reversibly bind to the activated and inactivated KRAS G12D mutants and inhibit their activity. The specificity of this compound to KRAS G12D is more than 1000 times that of wild-type KRAS |
References |
|
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.